Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Abstract On May 8, 2020, the FDA granted accelerated approval to selpercatinib for (i) adult
patients with metastatic RET fusion–positive non–small cell lung cancer (NSCLC),(ii) adult …

BACKGROUND. Poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer
(ATC) are rare and frequently lethal tumors that so far have not been subjected to …

Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the publication of the American Thyroid …

Background: Poorly differentiated thyroid cancer (PDTC) is a rare but clinically highly
significant entity because it accounts for most fatalities from non-anaplastic follicular cell …

Abstract The Japan Associations of Endocrine Surgeons has developed the revised version
of the Clinical Practice Guidelines for Thyroid Tumors. This article describes the guidelines …

Introduction Over the past years, the incidence of thyroid cancer has surged not only in
Germany but also in other countries of the Western hemisphere. This surge was first and …

Thyroid carcinoma consists a group of phenotypically heterogeneous cancers. Recent
advances in biological technologies have been advancing the delineation of genetic …

Diagnostic Pathology and Molecular Genetics of the Thyroid, Second Edition, offers a
comprehensive overview of the diagnostic surgical pathology, cytopathology …

Background: Poorly differentiated thyroid cancer (PDTC) accounts for only 1–15% of all
thyroid cancers. Our objective is to report outcomes in a large series of patients with PDTC …